Exact Mass: 1026.575

Exact Mass Matches: 1026.575

Found 97 metabolites which its exact mass value is equals to given mass value 1026.575, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PGP(a-25:0/PGF2alpha)

[(2S)-3-({[(2R)-2-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-3-[(22-methyltetracosanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy]phosphonic acid

C51H96O16P2 (1026.6173)


PGP(a-25:0/PGF2alpha) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(a-25:0/PGF2alpha), in particular, consists of one chain of one 22-methyltetracosanoyl at the C-1 position and one chain of Prostaglandin F2alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PGP(PGF2alpha/a-25:0)

[(2S)-3-({[(2R)-3-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-2-[(22-methyltetracosanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy]phosphonic acid

C51H96O16P2 (1026.6173)


PGP(PGF2alpha/a-25:0) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(PGF2alpha/a-25:0), in particular, consists of one chain of one Prostaglandin F2alpha at the C-1 position and one chain of 22-methyltetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PGP(a-25:0/PGE1)

[(2S)-2-hydroxy-3-({hydroxy[(2R)-2-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)-3-[(22-methyltetracosanoyl)oxy]propoxy]phosphoryl}oxy)propoxy]phosphonic acid

C51H96O16P2 (1026.6173)


PGP(a-25:0/PGE1) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(a-25:0/PGE1), in particular, consists of one chain of one 22-methyltetracosanoyl at the C-1 position and one chain of Prostaglandin E1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PGP(PGE1/a-25:0)

[(2S)-2-hydroxy-3-({hydroxy[(2R)-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)-2-[(22-methyltetracosanoyl)oxy]propoxy]phosphoryl}oxy)propoxy]phosphonic acid

C51H96O16P2 (1026.6173)


PGP(PGE1/a-25:0) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(PGE1/a-25:0), in particular, consists of one chain of one Prostaglandin E1 at the C-1 position and one chain of 22-methyltetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PGP(a-25:0/PGD1)

[(2S)-2-hydroxy-3-({hydroxy[(2R)-2-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)-3-[(22-methyltetracosanoyl)oxy]propoxy]phosphoryl}oxy)propoxy]phosphonic acid

C51H96O16P2 (1026.6173)


PGP(a-25:0/PGD1) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(a-25:0/PGD1), in particular, consists of one chain of one 22-methyltetracosanoyl at the C-1 position and one chain of Prostaglandin D1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PGP(PGD1/a-25:0)

[(2S)-2-hydroxy-3-({hydroxy[(2R)-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)-2-[(22-methyltetracosanoyl)oxy]propoxy]phosphoryl}oxy)propoxy]phosphonic acid

C51H96O16P2 (1026.6173)


PGP(PGD1/a-25:0) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(PGD1/a-25:0), in particular, consists of one chain of one Prostaglandin D1 at the C-1 position and one chain of 22-methyltetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

{[(1R,3S)-3-({[(2R)-2-{[(5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoyl]oxy}-3-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)), in particular, consists of one chain of eicosanoyl at the C-1 position and one chain of Leukotriene B4 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0)

{[(1R,3S)-3-({[(2R)-3-{[(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoyl]oxy}-2-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0), in particular, consists of one chain of Leukotriene B4 at the C-1 position and one chain of eicosanoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

{[(1R,3S)-3-({[(2R)-2-{[(5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoyl]oxy}-3-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)), in particular, consists of one chain of eicosanoyl at the C-1 position and one chain of 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0)

{[(1R,3S)-3-({[(2R)-3-{[(5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoyl]oxy}-2-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0), in particular, consists of one chain of 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of eicosanoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

{[(1R,3S)-3-({[(2R)-2-{[(5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoyl]oxy}-3-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)), in particular, consists of one chain of eicosanoyl at the C-1 position and one chain of 5,6-Dihydroxyeicosatetraenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0)

{[(1R,3S)-3-({[(2R)-3-{[(5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoyl]oxy}-2-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0), in particular, consists of one chain of 5,6-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of eicosanoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6))

{[(1R,3S)-3-({[(2R)-2-{[(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoyl]oxy}-3-[(11Z)-icos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6)), in particular, consists of one chain of 11Z-eicosenoyl at the C-1 position and one chain of 5,6-dihydroxyeicosatrienoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z))

{[(1R,3S)-3-({[(2R)-3-{[(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoyl]oxy}-2-[(11Z)-icos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z)), in particular, consists of one chain of 5,6-dihydroxyeicosatrienoyl at the C-1 position and one chain of 11Z-eicosenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   
   
   
   
   
   

caminoside A

caminoside A

C49H86O22 (1026.561)


A glycolipid with an unusual non-glycerol aglycone, 10-hydroxynonadecan-2-one that is glycosylated at the C10 hydroxy group by a branched tetrasaccharide residue. It is isolated from the marine sponge Caminus sphaeroconia and exhibits potent activity as an inhibitor of a type III bacterial secretory system.

   

alternoside XVI|chichipegenin 22-O-tigloyl-3-O-beta-D-glucopyranosyl(1->3)-beta-D-glucuronopyranosyl-28-O-beta-D-xylopyranoside

alternoside XVI|chichipegenin 22-O-tigloyl-3-O-beta-D-glucopyranosyl(1->3)-beta-D-glucuronopyranosyl-28-O-beta-D-xylopyranoside

C52H82O20 (1026.5399)


   
   
   
   

methylspirastrellolide A|spirastrellolide A methyl ester

methylspirastrellolide A|spirastrellolide A methyl ester

C53H83ClO17 (1026.5318)


   
   
   

PGP(a-25:0/PGF2alpha)

PGP(a-25:0/PGF2alpha)

C51H96O16P2 (1026.6173)


   

PGP(PGF2alpha/a-25:0)

PGP(PGF2alpha/a-25:0)

C51H96O16P2 (1026.6173)


   
   
   
   
   

PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C49H88O18P2 (1026.5446)


   

PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0)

PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0)

C49H88O18P2 (1026.5446)


   

PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C49H88O18P2 (1026.5446)


   

PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0)

PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0)

C49H88O18P2 (1026.5446)


   

PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C49H88O18P2 (1026.5446)


   

PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0)

PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0)

C49H88O18P2 (1026.5446)


   

PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6))

PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6))

C49H88O18P2 (1026.5446)


   

PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z))

PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z))

C49H88O18P2 (1026.5446)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoate

C53H88O15P2 (1026.5598)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(7E,9E,11Z,13E,15E,17Z)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (12Z,15Z,18Z)-tetracosa-12,15,18-trienoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(7E,9E,11Z,13E,15E,17Z)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (12Z,15Z,18Z)-tetracosa-12,15,18-trienoate

C53H88O15P2 (1026.5598)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

C53H88O15P2 (1026.5598)


   

[3-[[3-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

[3-[[3-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C53H88O15P2 (1026.5598)


   

[3-[[3-[[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate

[3-[[3-[[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate

C53H88O15P2 (1026.5598)


   

[3-[[3-[[3-[(7E,9E,11E,13E,15Z,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (13Z,16Z)-docosa-13,16-dienoate

[3-[[3-[[3-[(7E,9E,11E,13E,15Z,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (13Z,16Z)-docosa-13,16-dienoate

C53H88O15P2 (1026.5598)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (3Z,6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-3,6,9,12,15,18,21-heptaenoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (3Z,6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-3,6,9,12,15,18,21-heptaenoate

C53H88O15P2 (1026.5598)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoate

C53H88O15P2 (1026.5598)


   

[1-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate

[1-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate

C51H96O16P2 (1026.6173)


   
   
   
   
   
   

methyl 9-{33-chloro-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.1¹,⁴.1⁸,¹².1¹⁸,²².1²²,²⁶.1³²,³⁶]pentatetracont-20-en-3-yl}-2-hydroxynona-4,7-dienoate

methyl 9-{33-chloro-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.1¹,⁴.1⁸,¹².1¹⁸,²².1²²,²⁶.1³²,³⁶]pentatetracont-20-en-3-yl}-2-hydroxynona-4,7-dienoate

C53H83ClO17 (1026.5318)


   

15-(7-{3-[2-(4-{[4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl)-1,3-oxazol-4-yl]prop-2-en-1-yl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl)-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

15-(7-{3-[2-(4-{[4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl)-1,3-oxazol-4-yl]prop-2-en-1-yl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl)-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

methyl (2r,4z,7e)-9-[(1r,3s,4s,8r,12s,14s,16s,18r,19s,22r,25s,26r,27s,28s,29s,32r,33s,34r,36r,39s)-33-chloro-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.1¹,⁴.1⁸,¹².1¹⁸,²².1²²,²⁶.1³²,³⁶]pentatetracont-20-en-3-yl]-2-hydroxynona-4,7-dienoate

methyl (2r,4z,7e)-9-[(1r,3s,4s,8r,12s,14s,16s,18r,19s,22r,25s,26r,27s,28s,29s,32r,33s,34r,36r,39s)-33-chloro-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.1¹,⁴.1⁸,¹².1¹⁸,²².1²²,²⁶.1³²,³⁶]pentatetracont-20-en-3-yl]-2-hydroxynona-4,7-dienoate

C53H83ClO17 (1026.5318)


   

(2r,3r,4s,5r,6s)-6-{[(3r,4r,4as,5r,6as,6br,8ar,9s,10s,12ar,12br,14bs)-5,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-4-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-5-(acetyloxy)-2-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}oxan-3-yl (2z)-2-methylbut-2-enoate

(2r,3r,4s,5r,6s)-6-{[(3r,4r,4as,5r,6as,6br,8ar,9s,10s,12ar,12br,14bs)-5,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-4-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-5-(acetyloxy)-2-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}oxan-3-yl (2z)-2-methylbut-2-enoate

C56H82O17 (1026.5552)


   

(2z,4e,6e,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2z,4e,6e,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

5,8,14,17,20-pentahydroxy-3-[hydroxy({1-[2-(oxiran-2-yl)propan-2-yl]indol-3-yl})methyl]-12-isopropyl-15-[methoxy(phenyl)methyl]-1,10,18-trimethyl-6-(4-methylpent-3-en-2-yl)-9,21-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

5,8,14,17,20-pentahydroxy-3-[hydroxy({1-[2-(oxiran-2-yl)propan-2-yl]indol-3-yl})methyl]-12-isopropyl-15-[methoxy(phenyl)methyl]-1,10,18-trimethyl-6-(4-methylpent-3-en-2-yl)-9,21-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

C56H82N8O10 (1026.6154)


   

n-[38-(2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl)-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecahydroxy-34,36-dimethyl-38-oxooctatriacont-36-en-1-yl]carboximidic acid

n-[38-(2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl)-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecahydroxy-34,36-dimethyl-38-oxooctatriacont-36-en-1-yl]carboximidic acid

C53H90N2O17 (1026.6239)


   

(7r,10s,13s,19s,22s,25s,28s,29r)-10-(3-carbamimidamidopropyl)-9,12,21,24,27-pentahydroxy-28-({hydroxy[(2s)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]methylidene}amino)-22,29-diisopropyl-25-(2-methylpropyl)-18-oxo-2,4,8,11,17,20,23,26,35-nonaazahexacyclo[17.16.2.1²,⁵.1³⁰,³⁴.0¹³,¹⁷.0³³,³⁶]nonatriaconta-1(36),3,5(39),8,11,20,23,26,30,32,34(38)-undecaene-7-carboxylic acid

(7r,10s,13s,19s,22s,25s,28s,29r)-10-(3-carbamimidamidopropyl)-9,12,21,24,27-pentahydroxy-28-({hydroxy[(2s)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]methylidene}amino)-22,29-diisopropyl-25-(2-methylpropyl)-18-oxo-2,4,8,11,17,20,23,26,35-nonaazahexacyclo[17.16.2.1²,⁵.1³⁰,³⁴.0¹³,¹⁷.0³³,³⁶]nonatriaconta-1(36),3,5(39),8,11,20,23,26,30,32,34(38)-undecaene-7-carboxylic acid

C50H70N14O10 (1026.5399)


   

(3s,6s,9s,12s,15s,18s,21s)-5,8,14,17,20-pentahydroxy-3-[(r)-hydroxy(1-{2-[(2r)-oxiran-2-yl]propan-2-yl}indol-3-yl)methyl]-12-isopropyl-15-[(r)-methoxy(phenyl)methyl]-1,10,18-trimethyl-6-[(2r)-4-methylpent-3-en-2-yl]-9,21-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

(3s,6s,9s,12s,15s,18s,21s)-5,8,14,17,20-pentahydroxy-3-[(r)-hydroxy(1-{2-[(2r)-oxiran-2-yl]propan-2-yl}indol-3-yl)methyl]-12-isopropyl-15-[(r)-methoxy(phenyl)methyl]-1,10,18-trimethyl-6-[(2r)-4-methylpent-3-en-2-yl]-9,21-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

C56H82N8O10 (1026.6154)


   

(2r,3r,4r,5r,6s)-6-{[(2r,3r,4s,6s)-6-{[(2r,3r,4s,6r)-6-{[(1s,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-[(1s)-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl]oxy}-4-methoxy-2-methyloxan-3-yl]oxy}-5-hydroxy-4-methoxy-2-methyloxan-3-yl (2e)-2-methylbut-2-enoate

(2r,3r,4r,5r,6s)-6-{[(2r,3r,4s,6s)-6-{[(2r,3r,4s,6r)-6-{[(1s,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-[(1s)-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl]oxy}-4-methoxy-2-methyloxan-3-yl]oxy}-5-hydroxy-4-methoxy-2-methyloxan-3-yl (2e)-2-methylbut-2-enoate

C53H86O19 (1026.5763)


   

(2s,3r,4r,5r,6s)-2-{[(2r,3r,4s,5s,6r)-2-{[(2s,4ar,4bs,6as,7r,11as,11br)-4a,6a,7-trimethyl-8-(3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-1h,2h,3h,4h,4bh,5h,6h,7h,8h,11h,11ah,11bh,12h-indeno[2,1-a]phenanthren-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

(2s,3r,4r,5r,6s)-2-{[(2r,3r,4s,5s,6r)-2-{[(2s,4ar,4bs,6as,7r,11as,11br)-4a,6a,7-trimethyl-8-(3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-1h,2h,3h,4h,4bh,5h,6h,7h,8h,11h,11ah,11bh,12h-indeno[2,1-a]phenanthren-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C52H82O20 (1026.5399)


   

n-[(2s,3s,4r,6r)-6-{[(3s,6s,13r,16r,17r,18r,20r,21s,22r)-17-{[(2s,4r,5s,6s)-4-{[(2r,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-23-hydroxy-3,4,8,12,18,20,22-heptamethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl]methoxycarboximidic acid

n-[(2s,3s,4r,6r)-6-{[(3s,6s,13r,16r,17r,18r,20r,21s,22r)-17-{[(2s,4r,5s,6s)-4-{[(2r,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-23-hydroxy-3,4,8,12,18,20,22-heptamethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl]methoxycarboximidic acid

C54H78N2O17 (1026.53)


   

(2r,3r,4r,5r,6s)-6-{[(2r,3r,4s,6s)-6-{[(2r,3r,4s,6r)-6-{[(1s,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-[(1s)-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl]oxy}-4-methoxy-2-methyloxan-3-yl]oxy}-5-hydroxy-4-methoxy-2-methyloxan-3-yl (2e)-2-methylbut-2-enoate

(2r,3r,4r,5r,6s)-6-{[(2r,3r,4s,6s)-6-{[(2r,3r,4s,6r)-6-{[(1s,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-[(1s)-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl]oxy}-4-methoxy-2-methyloxan-3-yl]oxy}-5-hydroxy-4-methoxy-2-methyloxan-3-yl (2e)-2-methylbut-2-enoate

C53H86O19 (1026.5763)


   

(3s,6s,9s,12s,15s,18s,21s)-5,8,14,17,20-pentahydroxy-21-[(2r)-3-hydroxy-2-methylpropyl]-3-[(r)-hydroxy[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl]-12-isopropyl-15-[(r)-methoxy(phenyl)methyl]-1,10,18-trimethyl-6-[(2r)-4-methylpent-3-en-2-yl]-9-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

(3s,6s,9s,12s,15s,18s,21s)-5,8,14,17,20-pentahydroxy-21-[(2r)-3-hydroxy-2-methylpropyl]-3-[(r)-hydroxy[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl]-12-isopropyl-15-[(r)-methoxy(phenyl)methyl]-1,10,18-trimethyl-6-[(2r)-4-methylpent-3-en-2-yl]-9-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

C56H82N8O10 (1026.6154)


   

(2z,4e,6e,8e,10s,11s,12r,13r,15r)-15-[(2s,3s,5s,7r,8r,9s)-7-[(2e)-3-{2-[(2r)-4-{[(2r,3r,4r)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2z,4e,6e,8e,10s,11s,12r,13r,15r)-15-[(2s,3s,5s,7r,8r,9s)-7-[(2e)-3-{2-[(2r)-4-{[(2r,3r,4r)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8as,10s,12as,12br,14bs)-10-[(2s,3s,4r,5r,6r)-3-hydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8as,10s,12as,12br,14bs)-10-[(2s,3s,4r,5r,6r)-3-hydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C52H82O20 (1026.5399)


   

n-[(2r,3r,4s,6r)-6-{[(1s,3r,6s,7e,9s,11e,13s,16s,17s,18s,20s,21r,22s)-17-{[(2r,4r,5s,6s)-4-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-23-hydroxy-3,4,8,12,18,20,22-heptamethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl]methoxycarboximidic acid

n-[(2r,3r,4s,6r)-6-{[(1s,3r,6s,7e,9s,11e,13s,16s,17s,18s,20s,21r,22s)-17-{[(2r,4r,5s,6s)-4-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-23-hydroxy-3,4,8,12,18,20,22-heptamethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl]methoxycarboximidic acid

C54H78N2O17 (1026.53)


   

(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8s,8ar,9s,12as,14ar,14br)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-9-{[(2e)-2-methylbut-2-enoyl]oxy}-8a-({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,5-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8s,8ar,9s,12as,14ar,14br)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-9-{[(2e)-2-methylbut-2-enoyl]oxy}-8a-({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,5-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid

C52H82O20 (1026.5399)


   

6-({6-[(6-{[3a-hydroxy-9a,11a-dimethyl-1-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl)oxy]-4-methoxy-2-methyloxan-3-yl}oxy)-5-hydroxy-4-methoxy-2-methyloxan-3-yl 2-methylbut-2-enoate

6-({6-[(6-{[3a-hydroxy-9a,11a-dimethyl-1-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl)oxy]-4-methoxy-2-methyloxan-3-yl}oxy)-5-hydroxy-4-methoxy-2-methyloxan-3-yl 2-methylbut-2-enoate

C53H86O19 (1026.5763)


   

(7s,10s,13s,19s,22s,25s,28s,29r)-10-(3-carbamimidamidopropyl)-9,12,21,24,27-pentahydroxy-28-({hydroxy[(2s)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]methylidene}amino)-22,29-diisopropyl-25-(2-methylpropyl)-18-oxo-2,4,8,11,17,20,23,26,35-nonaazahexacyclo[17.16.2.1²,⁵.1³⁰,³⁴.0¹³,¹⁷.0³³,³⁶]nonatriaconta-1(36),3,5(39),8,11,20,23,26,30,32,34(38)-undecaene-7-carboxylic acid

(7s,10s,13s,19s,22s,25s,28s,29r)-10-(3-carbamimidamidopropyl)-9,12,21,24,27-pentahydroxy-28-({hydroxy[(2s)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]methylidene}amino)-22,29-diisopropyl-25-(2-methylpropyl)-18-oxo-2,4,8,11,17,20,23,26,35-nonaazahexacyclo[17.16.2.1²,⁵.1³⁰,³⁴.0¹³,¹⁷.0³³,³⁶]nonatriaconta-1(36),3,5(39),8,11,20,23,26,30,32,34(38)-undecaene-7-carboxylic acid

C50H70N14O10 (1026.5399)


   

(2r)-2-{[(2s,3s,4e,6e,8s,9s)-3-{[(2s)-2-{[(2s,3r)-3-{[(2s,4s)-2-amino-1-hydroxy-4-methylhexylidene]amino}-3-carboxy-1-hydroxy-2-methylpropylidene]amino}-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxy-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dien-1-ylidene]amino}-4-[(1-{[(1r)-1-carboxyethyl]-c-hydroxycarbonimidoyl}eth-1-en-1-yl)(methyl)carbamoyl]butanoic acid

(2r)-2-{[(2s,3s,4e,6e,8s,9s)-3-{[(2s)-2-{[(2s,3r)-3-{[(2s,4s)-2-amino-1-hydroxy-4-methylhexylidene]amino}-3-carboxy-1-hydroxy-2-methylpropylidene]amino}-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxy-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dien-1-ylidene]amino}-4-[(1-{[(1r)-1-carboxyethyl]-c-hydroxycarbonimidoyl}eth-1-en-1-yl)(methyl)carbamoyl]butanoic acid

C50H78N10O13 (1026.575)


   

(3s,6s,9s,12s,15s,18s,21s)-5,8,14,17,20-pentahydroxy-21-[(2r)-3-hydroxy-2-methylpropyl]-3-{hydroxy[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-12-isopropyl-15-[(r)-methoxy(phenyl)methyl]-1,10,18-trimethyl-6-[(2r)-4-methylpent-3-en-2-yl]-9-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

(3s,6s,9s,12s,15s,18s,21s)-5,8,14,17,20-pentahydroxy-21-[(2r)-3-hydroxy-2-methylpropyl]-3-{hydroxy[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-12-isopropyl-15-[(r)-methoxy(phenyl)methyl]-1,10,18-trimethyl-6-[(2r)-4-methylpent-3-en-2-yl]-9-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

C56H82N8O10 (1026.6154)


   

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2r,3r,4s,5s)-3-{[(2s,3r,4r,5s,6s)-4-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2r,3r,4s,5s)-3-{[(2s,3r,4r,5s,6s)-4-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C52H82O20 (1026.5399)


   

10-(3-carbamimidamidopropyl)-9,12,21,24,27-pentahydroxy-28-{[hydroxy(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)methylidene]amino}-22,29-diisopropyl-25-(2-methylpropyl)-18-oxo-2,4,8,11,17,20,23,26,35-nonaazahexacyclo[17.16.2.1²,⁵.1³⁰,³⁴.0¹³,¹⁷.0³³,³⁶]nonatriaconta-1(36),3,5(39),8,11,20,23,26,30,32,34(38)-undecaene-7-carboxylic acid

10-(3-carbamimidamidopropyl)-9,12,21,24,27-pentahydroxy-28-{[hydroxy(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)methylidene]amino}-22,29-diisopropyl-25-(2-methylpropyl)-18-oxo-2,4,8,11,17,20,23,26,35-nonaazahexacyclo[17.16.2.1²,⁵.1³⁰,³⁴.0¹³,¹⁷.0³³,³⁶]nonatriaconta-1(36),3,5(39),8,11,20,23,26,30,32,34(38)-undecaene-7-carboxylic acid

C50H70N14O10 (1026.5399)


   

(2e,4e)-15-(7-{3-[2-(4-{[4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl)-1,3-oxazol-4-yl]prop-2-en-1-yl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl)-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2e,4e)-15-(7-{3-[2-(4-{[4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl)-1,3-oxazol-4-yl]prop-2-en-1-yl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl)-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

n-[(2s,4r,6r,8r,10r,12r,14r,16r,18r,20r,22r,24r,26s,34r,36z)-38-[(2s)-2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl]-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecahydroxy-34,36-dimethyl-38-oxooctatriacont-36-en-1-yl]carboximidic acid

n-[(2s,4r,6r,8r,10r,12r,14r,16r,18r,20r,22r,24r,26s,34r,36z)-38-[(2s)-2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl]-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecahydroxy-34,36-dimethyl-38-oxooctatriacont-36-en-1-yl]carboximidic acid

C53H90N2O17 (1026.6239)


   

(2r,3r,4s,5r,6s)-6-{[(3r,4r,4ar,5r,6as,6br,8ar,9s,10s,12ar,12br,14bs)-4,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-5-(acetyloxy)-2-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}oxan-3-yl (2z)-2-methylbut-2-enoate

(2r,3r,4s,5r,6s)-6-{[(3r,4r,4ar,5r,6as,6br,8ar,9s,10s,12ar,12br,14bs)-4,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-5-(acetyloxy)-2-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}oxan-3-yl (2z)-2-methylbut-2-enoate

C56H82O17 (1026.5552)


   

n-(6-{[17-({4-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-5-hydroxy-6-methyloxan-2-yl}oxy)-23-hydroxy-3,4,8,12,18,20,22-heptamethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl)methoxycarboximidic acid

n-(6-{[17-({4-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-5-hydroxy-6-methyloxan-2-yl}oxy)-23-hydroxy-3,4,8,12,18,20,22-heptamethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,11,14,23-pentaen-9-yl]oxy}-2,4-dimethyl-4-nitrooxan-3-yl)methoxycarboximidic acid

C54H78N2O17 (1026.53)


   

(2e,4e,6z,8e,10s,11s,12r,13r,15r)-15-[(2s,3s,5s,7r,8r,9s)-7-[(2e)-3-{2-[(2r)-4-{[(2r,3r,4r)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2e,4e,6z,8e,10s,11s,12r,13r,15r)-15-[(2s,3s,5s,7r,8r,9s)-7-[(2e)-3-{2-[(2r)-4-{[(2r,3r,4r)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

3-(acetyloxy)-2-{[4,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-6-methyl-5-[(2-methylbut-2-enoyl)oxy]oxan-4-yl 2-methylbut-2-enoate

3-(acetyloxy)-2-{[4,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-6-methyl-5-[(2-methylbut-2-enoyl)oxy]oxan-4-yl 2-methylbut-2-enoate

C56H82O17 (1026.5552)


   

(2e,4e,6z,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2e,4e,6z,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

(7s,10s,13s,19s,22s,25s,28s,29r)-25-[(2r)-butan-2-yl]-10-(3-carbamimidamidopropyl)-9,12,21,24,27-pentahydroxy-28-({hydroxy[(2s)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]methylidene}amino)-22,29-diisopropyl-18-oxo-2,4,8,11,17,20,23,26,35-nonaazahexacyclo[17.16.2.1²,⁵.1³⁰,³⁴.0¹³,¹⁷.0³³,³⁶]nonatriaconta-1(36),3,5(39),8,11,20,23,26,30,32,34(38)-undecaene-7-carboxylic acid

(7s,10s,13s,19s,22s,25s,28s,29r)-25-[(2r)-butan-2-yl]-10-(3-carbamimidamidopropyl)-9,12,21,24,27-pentahydroxy-28-({hydroxy[(2s)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]methylidene}amino)-22,29-diisopropyl-18-oxo-2,4,8,11,17,20,23,26,35-nonaazahexacyclo[17.16.2.1²,⁵.1³⁰,³⁴.0¹³,¹⁷.0³³,³⁶]nonatriaconta-1(36),3,5(39),8,11,20,23,26,30,32,34(38)-undecaene-7-carboxylic acid

C50H70N14O10 (1026.5399)


   

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-3-{[(2s,3r,4r,5s,6s)-4-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-3-{[(2s,3r,4r,5s,6s)-4-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C52H82O20 (1026.5399)


   

(3e,5e,7s,8s,11e,13e,15s,16s)-8-[(2s,3r,4s)-4-[(2r,4r,5r,6r)-4-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-ethyl-2-hydroxy-6-methyloxan-2-yl]-3-hydroxypentan-2-yl]-16-[(2s,3r,4s)-4-[(2r,4r,5r,6r)-5-ethyl-2-hydroxy-6-methyl-4-{[(2r,4s,5s,6r)-4,5,6-trihydroxyoxan-2-yl]oxy}oxan-2-yl]-3-hydroxypentan-2-yl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione

(3e,5e,7s,8s,11e,13e,15s,16s)-8-[(2s,3r,4s)-4-[(2r,4r,5r,6r)-4-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-ethyl-2-hydroxy-6-methyloxan-2-yl]-3-hydroxypentan-2-yl]-16-[(2s,3r,4s)-4-[(2r,4r,5r,6r)-5-ethyl-2-hydroxy-6-methyl-4-{[(2r,4s,5s,6r)-4,5,6-trihydroxyoxan-2-yl]oxy}oxan-2-yl]-3-hydroxypentan-2-yl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione

C53H86O19 (1026.5763)


   

3-(acetyloxy)-2-{[5,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-4-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-6-methyl-5-[(2-methylbut-2-enoyl)oxy]oxan-4-yl 2-methylbut-2-enoate

3-(acetyloxy)-2-{[5,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-4-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-6-methyl-5-[(2-methylbut-2-enoyl)oxy]oxan-4-yl 2-methylbut-2-enoate

C56H82O17 (1026.5552)


   

(2e,4e,6e,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2e,4e,6e,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

5,8,14,17,20-pentahydroxy-21-(3-hydroxy-2-methylpropyl)-3-{hydroxy[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-12-isopropyl-15-[methoxy(phenyl)methyl]-1,10,18-trimethyl-6-(4-methylpent-3-en-2-yl)-9-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

5,8,14,17,20-pentahydroxy-21-(3-hydroxy-2-methylpropyl)-3-{hydroxy[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-12-isopropyl-15-[methoxy(phenyl)methyl]-1,10,18-trimethyl-6-(4-methylpent-3-en-2-yl)-9-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-4,7,13,16,19-pentaene-2,11-dione

C56H82N8O10 (1026.6154)


   

10-({3-[(4-{[3,5-dihydroxy-6-(hydroxymethyl)-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-4,5-dihydroxyoxan-2-yl}oxy)-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

10-({3-[(4-{[3,5-dihydroxy-6-(hydroxymethyl)-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-4,5-dihydroxyoxan-2-yl}oxy)-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C52H82O20 (1026.5399)


   

3-(acetyloxy)-6-{[4,5-dihydroxy-6-(hydroxymethyl)-2-[(2-oxononadecan-10-yl)oxy]oxan-3-yl]oxy}-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-4-yl butanoate

3-(acetyloxy)-6-{[4,5-dihydroxy-6-(hydroxymethyl)-2-[(2-oxononadecan-10-yl)oxy]oxan-3-yl]oxy}-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-4-yl butanoate

C49H86O22 (1026.561)